Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hope for men with Hard-to-Treat prostate cancer?

NCT ID NCT06764485

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 09, 2026 · Updated 6 times

Summary

This phase 3 trial compares a new drug, BMS-986365, against standard treatments (docetaxel or other hormone therapies) in 960 men with metastatic castration-resistant prostate cancer that has stopped responding to hormone therapy. The main goal is to see if the new drug delays cancer growth or improves survival. Participants are randomly assigned to receive either the new drug or a standard therapy chosen by their doctor.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
BMS-986365
What this could lead to
If successful, this could provide a new treatment option that delays cancer progression and extends survival for men with metastatic castration-resistant prostate cancer.
What could go wrong
This is an early-stage comparison; the new drug may not prove superior to existing therapies. Side effects and tolerability are still being evaluated.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 960 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2025

Expected to finish

Jan 2029

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria * Participants must have histologic or cytologic confirmation of adenocarcinoma of the prostate without small cell or neuro-endocrine features. * Participants must have current evidence of metastatic disease documented by either bone lesions on radionuclide bone scan and/or soft tissue lesions on computed tomography/magnetic resonance imaging (CT/MRI). * Participants must be asymptomatic or mildly symptomatic from prostate cancer with score on Brief Pain Inventory - Short Form (BPI-SF) that must be \< 4. * Participants must have had previous treatment with an androgen receptor pathway inhibitor (abiraterone, enzalutamide, apalutamide, or darolutamide). Exclusion Criteria * Participants must not have impaired cardiac function or clinically significant cardiac disease. * Participants must not have any brain metastasis. * Participants must not have any liver metastasis. * Participants with superscan on technetium-99m (Tc-99m) radionuclide bone scans. * Other protocol-defined Inclusion/Exclusion criteria apply.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Metastatic castration resistant prostate cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Local Institution - 0004

    Prague, Praha 5, 150 06, Czechia

  • Local Institution - 0005

    Hradec Králové, Hradec Králové, 500 05, Czechia

  • Local Institution - 0006

    Prague, 128 08, Czechia

  • Local Institution - 0008

    Brno, Brno-město, 656 53, Czechia

  • Local Institution - 0009

    Prague, Praha 2, 120 00, Czechia

  • Local Institution - 0010

    Olomouc, Olomouc Region, 779 00, Czechia

  • Local Institution - 0015

    La Jolla, California, 92093, United States

  • Local Institution - 0016

    San Francisco, California, 94115, United States

  • Local Institution - 0018

    Austin, Texas, 78705, United States

  • Local Institution - 0019

    Baltimore, Maryland, 21287, United States

  • Local Institution - 0025

    Belo Horizonte, Minas Gerais, 30110-022, Brazil

  • Local Institution - 0026

    Porto Alegre, Rio Grande do Sul, 90035-001, Brazil

  • Local Institution - 0031

    São Paulo, São Paulo, 01509-010, Brazil

  • Local Institution - 0035

    Natal, Rio Grande do Norte, 59075-740, Brazil

  • Local Institution - 0042

    Houston, Texas, 77030, United States

  • Local Institution - 0048

    Chicago, Illinois, 60611, United States

  • Local Institution - 0050

    Charlottesville, Virginia, 22903, United States

  • Local Institution - 0054

    Baltimore, Maryland, 21204, United States

  • Local Institution - 0055

    Charleston, South Carolina, 29425, United States

  • Local Institution - 0056

    Columbus, Ohio, 43210, United States

  • Local Institution - 0057

    Philadelphia, Pennsylvania, 19111, United States

  • Local Institution - 0060

    Wichita, Kansas, 67226, United States

  • Local Institution - 0067

    Portland, Oregon, 97213, United States

  • Local Institution - 0069

    New York, New York, 10016, United States

  • Local Institution - 0071

    New York, New York, 10065, United States

  • Local Institution - 0076

    New York, New York, 10029, United States

  • Local Institution - 0077

    Athens, Georgia, 30607, United States

  • Local Institution - 0078

    Seattle, Washington, 98109, United States

  • Local Institution - 0079

    Myrtle Beach, South Carolina, 29572, United States

  • Local Institution - 0081

    Albuquerque, New Mexico, 87106, United States

  • Local Institution - 0085

    New York, New York, 10032, United States

  • Local Institution - 0093

    Chicoutimi, Quebec, G7H 5H6, Canada

  • Local Institution - 0095

    Gothenburg, Västra Götalands Län [se-14], 413 45, Sweden

  • Local Institution - 0097

    Uppsala, Uppsala Län [se-03], 751 85, Sweden

  • Local Institution - 0098

    Copenhagen, Capital Region, DK-2100, Denmark

  • Local Institution - 0099

    Lund, Skåne Län [se-12], 22185, Sweden

  • Local Institution - 0100

    Aalborg, North Denmark, 9000, Denmark

  • Local Institution - 0109

    Murray, Utah, 84107, United States

  • Local Institution - 0112

    Milwaukee, Wisconsin, 53226, United States

  • Local Institution - 0114

    Austin, Texas, 78745, United States

  • Local Institution - 0117

    Yauco, 00698, Puerto Rico

  • Local Institution - 0124

    Ciudad Autónoma de Buenos Aires, Buenos Aires, C1426ANZ, Argentina

  • Local Institution - 0125

    CABA, Buenos Aires, CP1280AEB, Argentina

  • Local Institution - 0127

    Viña del Mar, Valparaiso, 2520598, Chile

  • Local Institution - 0128

    ABB, Buenos Aires F.D., C1199ABB, Argentina

  • Local Institution - 0129

    Buenos Aires, C1419AHN, Argentina

  • Local Institution - 0130

    Río Cuarto, Córdoba Province, X5800AEV, Argentina

  • Local Institution - 0132

    Santiago, Santiago Metropolitan, 8420383, Chile

  • Local Institution - 0135

    Santiago, Santiago Metropolitan, 7500921, Chile

  • Local Institution - 0136

    Viedma, R, R8500ACE, Argentina

  • Local Institution - 0139

    Craiova, Dolj, 200542, Romania

  • Local Institution - 0141

    Iași, 700483, Romania

  • Local Institution - 0142

    Ploieşti, 100337, Romania

  • Local Institution - 0144

    Cluj-Napoca, 400015, Romania

  • Local Institution - 0145

    Cluj-Napoca, 400015, Romania

  • Local Institution - 0149

    Montreal, Quebec, H3T 1E2, Canada

  • Local Institution - 0150

    Québec, Quebec, G1J 1Z4, Canada

  • Local Institution - 0151

    Halifax, Nova Scotia, B3H 2Y9, Canada

  • Local Institution - 0152

    Vancouver, British Columbia, V5Z 4E6, Canada

  • Local Institution - 0153

    Padova, Veneto, 35128, Italy

  • Local Institution - 0155

    Rome, Roma, 00144, Italy

  • Local Institution - 0156

    Arezzo, 52100, Italy

  • Local Institution - 0157

    Milan, Lombardy, 20133, Italy

  • Local Institution - 0158

    Trento, 38122, Italy

  • Local Institution - 0159

    Terni, 05100, Italy

  • Local Institution - 0160

    Naples, 80131, Italy

  • Local Institution - 0164

    Rimouski, Quebec, G5L 5T1, Canada

  • Local Institution - 0165

    Clermont-Ferrand, 63011, France

  • Local Institution - 0166

    Pierre-Bénite, Rhône, 69310, France

  • Local Institution - 0167

    Nice, Alpes-Maritimes, 06189, France

  • Local Institution - 0169

    Strasbourg, 67098, France

  • Local Institution - 0177

    Vandœuvre-lès-Nancy, Lorraine, 54519, France

  • Local Institution - 0179

    Villejuif, Val-de-Marne, 94800, France

  • Local Institution - 0180

    Guangzhou, Guangdong, 510180, China

  • Local Institution - 0185

    Bytom, Silesian Voivodeship, 41-902, Poland

  • Local Institution - 0186

    Gdansk, Pomeranian Voivodeship, 80-219, Poland

  • Local Institution - 0187

    Warsaw, Masovian Voivodeship, 02-507, Poland

  • Local Institution - 0189

    Bydgoszcz, 85796, Poland

  • Local Institution - 0190

    Opole, Opole Voivodeship, 45-061, Poland

  • Local Institution - 0191

    Jinan, Shandong, 250117, China

  • Local Institution - 0192

    Beijing, Beijing Municipality, 100034, China

  • Local Institution - 0193

    Toronto, Ontario, M4N 3M5, Canada

  • Local Institution - 0196

    Hangzhou, Zhejiang, 310014, China

  • Local Institution - 0197

    Buffalo, New York, 14263, United States

  • Local Institution - 0213

    Xiamen, Fujian, 361003, China

  • Local Institution - 0214

    Shanghai, Shanghai Municipality, 200032, China

  • Local Institution - 0218

    Ürümqi, Xinjiang, 830000, China

  • Local Institution - 0219

    Nanchang, Jiangxi, 330209, China

  • Local Institution - 0220

    Houston, Texas, 77030, United States

  • Local Institution - 0221

    Yantai, Shandong, 264099, China

  • Local Institution - 0224

    Los Alamitos, California, 90720, United States

  • Local Institution - 0225

    Syracuse, New York, 13210, United States

  • Local Institution - 0226

    Guangzhou, Guangdong, 510060, China

  • Local Institution - 0229

    Nanjing, Jiangsu, 210009, China

  • Local Institution - 0231

    Le Mans, Sarthe, 72000, France

  • Local Institution - 0232

    Hefei, Anhui, 230000, China

  • Local Institution - 0233

    Nanjing, Jiangsu, 210000, China

  • Local Institution - 0234

    Orbassano, Piedmont, 10043, Italy

  • Local Institution - 0235

    Córdoba, Córdoba Province, X5004BAL, Argentina

  • Local Institution - 0236

    Valdivia, Los Ríos Region, 5112129, Chile

  • Local Institution - 0238

    Aurora, Colorado, 80045, United States

  • Local Institution - 0240

    Chengdu, Sichuan, 610041, China

  • Local Institution - 0243

    Copenhagen, Capital Region, 2730, Denmark

  • Local Institution - 0248

    Manchester, M20 4BX, United Kingdom

  • Local Institution - 0249

    Fuzhou, Fujian, 350001, China

  • Local Institution - 0266

    London, London, City of, EC1A 7BE, United Kingdom

  • Local Institution - 0271

    Cork, T12 DC4A, Ireland

  • Local Institution - 0272

    Dublin, D24 NR0A, Ireland

  • Local Institution - 0273

    Dublin, D9, Ireland

  • Local Institution - 0278

    Chengdu, Sichuan, 610041, China

  • Local Institution - 0281

    Linhai, Zhejiang, 317000, China

  • Local Institution - 0283

    Chengdu, Sichuan, 610072, China

  • Local Institution - 0293

    Vancouver, Washington, 98684, United States

  • Local Institution - 0294

    Denver, Colorado, 80218, United States

  • Local Institution - 0304

    Kelowna, British Columbia, V1Y 5L3, Canada

  • Local Institution - 0305

    Montreal, Quebec, H4A 3J1, Canada

  • Local Institution - 0307

    Toulouse, Haute-Garonne, 31059, France

  • Local Institution - 0309

    Madrid, 28040, Spain

  • Local Institution - 0310

    Barcelona, Barcelona [Barcelona], 08035, Spain

  • Local Institution - 0311

    Sabadell, Barcelona [Barcelona], 08208, Spain

  • Local Institution - 0312

    Córdoba, Andalusia, 14004, Spain

  • Local Institution - 0313

    Seville, 41013, Spain

  • Local Institution - 0314

    Santander, Cantabria, 39008, Spain

  • Local Institution - 0315

    Barcelona, Catalunya [Cataluña], 08041, Spain

  • Local Institution - 0316

    Madrid, Madrid, Comunidad de, 28034, Spain

  • Local Institution - 0317

    Madrid, Madrid, Comunidad de, 28041, Spain

  • Local Institution - 0318

    Granada, 18008, Spain

  • Local Institution - 0319

    Lugo, Lugo [Lugo], 27003, Spain

  • Local Institution - 0320

    Badajoz, 06006, Spain

  • Local Institution - 0321

    Madrid, Madrid, Comunidad de, 28009, Spain

  • Local Institution - 0322

    Seville, 41009, Spain

  • Local Institution - 0323

    Madrid, Madrid, Comunidad de, 28046, Spain

  • Local Institution - 0324

    Valencia, 46026, Spain

  • Local Institution - 0325

    Barakaldo, Bizkaia, 48903, Spain

  • Local Institution - 0326

    Majadahonda, Madrid, Comunidad de, 28222, Spain

  • Local Institution - 0327

    Málaga, 29016, Spain

  • Local Institution - 0328

    Burgos, 09006, Spain

  • Local Institution - 0329

    Gilbert, Arizona, 85234, United States

  • Local Institution - 0330

    Birmingham, Alabama, 35209, United States

  • Local Institution - 0331

    Westwood, Kansas, 66205, United States

  • Local Institution - 0334

    Albuquerque, New Mexico, 87109, United States

  • Local Institution - 0335

    Nashville, Tennessee, 37203, United States

  • Local Institution - 0336

    Katowice, 40-519, Poland

  • Local Institution - 0344

    Frederick, Maryland, 21702, United States

  • Local Institution - 0345

    Philadelphia, Pennsylvania, 19104, United States

  • Local Institution - 0346

    Wroclaw, Lower Silesian Voivodeship, 53-329, Poland

  • Local Institution - 0347

    Greenslopes, Queensland, 4120, Australia

  • Local Institution - 0348

    Melbourne, Victoria, 3000, Australia

  • Local Institution - 0349

    Willow Grove, Pennsylvania, 19090, United States

  • Local Institution - 0351

    Southport, Queensland, 4215, Australia

  • Local Institution - 0352

    Kurralta Park, South Australia, 5037, Australia

  • Local Institution - 0353

    Malvern, Victoria, 3144, Australia

  • Local Institution - 0354

    Hobart, Tasmania, 7000, Australia

  • Local Institution - 0355

    Wahroonga, New South Wales, 2076, Australia

  • Local Institution - 0356

    Macquarie University, New South Wales, 2109, Australia

  • Local Institution - 0357

    Murdoch, Western Australia, 6150, Australia

  • Local Institution - 0358

    Elizabeth Vale, South Australia, 5112, Australia

  • Local Institution - 0359

    Darlinghurst, New South Wales, 2010, Australia

  • Local Institution - 0360

    Port Macquarie, New South Wales, 2444, Australia

  • Local Institution - 0361

    Melbourne, Victoria, 3004, Australia

  • Local Institution - 0362

    Adelaide, South Australia, 5000, Australia

  • Local Institution - 0363

    Heidelberg, Victoria, 3084, Australia

  • Local Institution - 0365

    Poznan, Greater Poland Voivodeship, 60-192, Poland

  • Local Institution - 0366

    Campbelltown, New South Wales, 2560, Australia

  • Local Institution - 0367

    Salzburg, 5020, Austria

  • Local Institution - 0368

    Vienna, 1090, Austria

  • Local Institution - 0369

    Krems, Lower Austria, 3500, Austria

  • Local Institution - 0370

    Anaheim, California, 92801, United States

  • Local Institution - 0371

    Lübeck, Schleswig-Holstein, 23538, Germany

  • Local Institution - 0372

    Würzburg, 97080, Germany

  • Local Institution - 0373

    Linz, Upper Austria, 4020, Austria

  • Local Institution - 0374

    München, Bavaria, 81675, Germany

  • Local Institution - 0375

    Essen, 45122, Germany

  • Local Institution - 0376

    Tübingen, 72076, Germany

  • Local Institution - 0377

    Herne, 44625, Germany

  • Local Institution - 0378

    Hamburg, 20246, Germany

  • Local Institution - 0379

    Heidelberg, D-69120, Germany

  • Local Institution - 0380

    Jena, Thuringia, 07747, Germany

  • Local Institution - 0381

    Prešov, Presov, 080 01, Slovakia

  • Local Institution - 0382

    Bonn, 53127, Germany

  • Local Institution - 0383

    Northwood, Hillingdon, HA6 2RN, United Kingdom

  • Local Institution - 0384

    Seoul, Seoul-teukbyeolsi [Seoul], 06351, South Korea

  • Local Institution - 0385

    Seoul, Seoul-teukbyeolsi [Seoul], 03080, South Korea

  • Local Institution - 0386

    Seongnam, Kyǒnggi-do, 13620, South Korea

  • Local Institution - 0387

    Seoul, Seoul-teukbyeolsi [Seoul], 03722, South Korea

  • Local Institution - 0388

    Seoul, Seoul-teukbyeolsi [Seoul], 05505, South Korea

  • Local Institution - 0389

    Goyang-si, Kyǒnggi-do, 10408, South Korea

  • Local Institution - 0391

    London, Sutton, SM2 5PT, United Kingdom

  • Local Institution - 0393

    Glasgow, Glasgow City, G12 0YN, United Kingdom

  • Local Institution - 0395

    São Paulo, São Paulo, 01308-060, Brazil

  • Local Institution - 0396

    Aarhus, Central Jutland, 8200, Denmark

  • Local Institution - 0397

    Taipei, 11217, Taiwan

  • Local Institution - 0398

    Taichung, 404332, Taiwan

  • Local Institution - 0399

    Taipei, 10002, Taiwan

  • Local Institution - 0406

    Pamplona, Navarre, 31009, Spain

  • Local Institution - 0407

    Ourense, Ourense [Orense], 32005, Spain

  • Local Institution - 0408

    Solna, Stockholms Län [se-01], 171 64, Sweden

  • Local Institution - 0409

    Foggia, 71100, Italy

  • Local Institution - 0411

    San Francisco, California, 94121, United States

  • Local Institution - 0412

    Mineola, New York, 11501, United States

  • Local Institution - 0413

    Washington D.C., District of Columbia, 20016, United States

  • Local Institution - 0414

    Philadelphia, Pennsylvania, 19107, United States

  • Local Institution - 0415

    Huizhou, Guangdong, 516001, China

  • Local Institution - 0416

    Portland, Oregon, 97225, United States

  • Local Institution - 0417

    Changzhou, Jiangsu, 213003, China

  • Local Institution - 0419

    Lakewood, Colorado, 80228, United States

  • Local Institution - 0420

    Taoyuan, 333, Taiwan

  • Local Institution - 0421

    Nürtingen, Baden-Wurttemberg, 72622, Germany

  • Local Institution - 0426

    Lakeland, Florida, 33805, United States

  • Local Institution - 0429

    Sewell, New Jersey, 08080, United States

  • Local Institution - 0430

    Córdoba, 5016, Argentina

  • Local Institution - 0432

    Dijon, Côte-d'Or, 21079, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.